Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Halving of Dexamethasone in Preterm Labor
NCT06350565Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of dexamethasone in respiratory distress syndrome (RDS) (4 arms), sponsored by Peking University Third Hospital. Primary endpoints: Respiratory distress syndrome, Pharmacokinetic parameters at 12 hours and 3 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT06350565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350565.